Reims, France

Cedric Castex

This inventor holds 1 USPTO granted patent. Top assignee: Neorphys. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cedric Castex. Retrieved from https://idiyas.com/inventor/cedric-castex

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cedric Castex: Innovator in Morphine Derivatives

Introduction

Cedric Castex is a notable inventor based in Reims, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of morphine derivatives. His work focuses on enhancing the efficacy and safety of pain management solutions.

Latest Patents

Cedric holds 1 patent for his invention related to morphine derivatives. The patent, titled "Morphine derivatives," pertains to new morphine-6-glucuronide derivatives, along with pharmaceutical compositions and their uses. This innovation aims to improve therapeutic outcomes for patients requiring pain relief.

Career Highlights

Cedric is currently associated with Neorphys, a company dedicated to advancing pharmaceutical research and development. His role involves leveraging his expertise to create innovative solutions in pain management. His work has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Cedric collaborates with esteemed colleagues, including Karine Larbouret and Roger Lahana. Together, they contribute to the advancement of pharmaceutical sciences and the development of new therapeutic agents.

Conclusion

Cedric Castex's contributions to the field of morphine derivatives highlight his commitment to improving pain management therapies. His innovative work continues to influence the pharmaceutical landscape positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…